Global Hyperpigmentation Disorder Treatment Market Size 2024, Forecast To 2033
6 Mar, 2024
The hyperpigmentation disorder treatment market size has shown significant growth in recent years, surging from $5.3 billion in 2023 to $5.69 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 7.5%. This growth is attributed to clinical trials and research, advances in chemical peels, a cultural shift towards skincare, emphasis on non-invasive options, and the demand for natural products. Looking ahead, the market is poised for strong growth, projected to reach $7.73 billion by 2028, with a CAGR of 7.9%. Anticipated drivers of this growth include a focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, and personalized treatment options. Major trends in the forecast period encompass innovative topical formulations, advancements in laser technologies, a focus on combination therapies, personalized treatment approaches, and rising demand for natural products.
Global Hyperpigmentation Disorder Treatment Market Key Driver
The hyperpigmentation disorders treatment market is set to experience substantial growth driven by the rising prevalence of pigmentation disorders. Pigmentation disorders affect the coloration of the skin, hair, and eye iris due to issues with melanin production. Treatment options for hyperpigmentation disorders include various topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone. According to the Centers for Disease Control (CDC) report in March 2023, the incidence of Candida auris cases surged from 476 in 2019 to 1,471 in 2021 in the US, with the number of cases being screened tripling between 2020 and 2021. Additionally, data from the National Psoriasis Foundation in December 2022 indicates that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders underscores the demand for hyperpigmentation disorders treatment, reflecting in market size estimates for 2023, 2024, and 2028.
Get A Free Sample Of The Global Hyperpigmentation Disorder Treatment Market ReportGlobal Hyperpigmentation Disorder Treatment Market Segments
The hyperpigmentation disorder treatment market covered in this report is segmented –
1) By Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, Other Treatments
2) By Disease Indication: Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines, Other Disease Indications
3) By End-Users: Hospitals, Esthetic Clinics And Dermatology Centers, Other End-Users
By Geography:The regions covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the hyperpigmentation disorders treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Hyperpigmentation Disorder Treatment Industry Players
Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.
Get The Full Global Hyperpigmentation Disorder Treatment Market ReportHyperpigmentation Disorder Treatment Market Overview
Hyperpigmentation disorder treatment refers to the various methods used to reduce the appearance of dark spots or patches on the skin that occur due to excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid can be used to lighten the skin.
Hyperpigmentation Disorder Treatment Global Market Report 2023 provides data on the global hyperpigmentation disorder treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hyperpigmentation disorder treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.